Brazil is among the countries most affected globally during the COVID-19 pandemic. To date, available data on the epidemiological and clinical features of the disease in Brazil are limited. COVID-19 has been associated with severe clinical outcomes among hospitalised patients, both direct as well as indirectly. As an example of it’s indirect implications, COVID-19 has been speculated to intersect with another top priority of globally health, namely antimicrobial resistance (AMR).

In this seminar, ITM alumna Dr Ana Paula Matos Porto (AIM, 2018), involved as a researcher in the COVID-19 outbreak in Brazil, will provide one of the few data-driven examples of the implications of COVID-19 for AMR and healthcare-associated infections, presenting data from 21 Brazilian ICUs in the early phase of the pandemic. Additionally, she will present her findings on COVID-19 hospital mortality in a dedicated tertiary hospital in Ceará (Northeastern Brazil). She will particularly focus on how factors associated with clinical outcomes of COVID-19 have evolved over the course of the pandemic.

Thursday, July 8, 2021
1:00 PM – 2:00 PM

SPEAKER
•    Dr Ana Paula Matos Porto, Researcher, School of Public Health of Ceará, Fortaleza, Brazil – Department of Infectious Diseases of Faculty of Medicine of University of São Paulo (São Paulo, Brazil)

MODERATOR
•    Dr Esther van Kleef, Senior epidemiologist, Department of Public Health @ Institute of Tropical Medicine, Antwerp, Belgium

Register in advance via Zoom.